Nanopharmaceuticals (part 2): products in the pipeline

References

• WeissigVPettingerTKMurdockNNanopharmaceuticals (part I): products on the marketInt J Nanomedicine201494357437325258527
   PubMed Web of Science ®Google Scholar
• Rivera GilPHuhnDdel MercatoLLSasseDParakWJNanopharmacy: inorganic nanoscale devices as vectors and active compoundsPharmacol Res201062211512520097288
   PubMed Web of Science ®Google Scholar
• International Council of Chemical Associations [homepage on the Internet] Available from: http://www.icca-chem.org/Accessed September 18, 2014
   Google Scholar
• National Institute for Occupational Safety and Health [homepage on the Internet] Available from: http://www.cdc.gov/niosh/docs/2009-125Accessed September 18, 2014
   Google Scholar
• Stanford University Environmental Health [homepage on the Internet] Available from: http://www.stanford.edu/dept/EHS/prod/Accessed September 18, 2014
   Google Scholar
• Nano.gov [homepage on the Internet]National Nanotechnology Initiative Available from: http://www.nano.gov/nanotech-101/specialAccessed September 18, 2014
   Google Scholar
• Nano.gov [homepage on the Internet] Available from: http://www.nano.gov/nanotechnology-initiative/nano-achievements/nanotechnology-initiatives/nano-achievementsAccessed May 6, 2014
   Google Scholar
• DuncanRRingsdorfHSatchi-FainaroRPolymer therapeutics-polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunitiesJ Drug Target200614633734117092834
   PubMed Web of Science ®Google Scholar
• StaudingerHViscosity investigations for the examination of the constitution of natuatrl products of high molecualr weight and of rubber and celluloseTrans Faraday Soc1933291832
   Google Scholar
• BatzHGFranzmannGRingsdorfHModel reactions for synthesis of pharmacologically active polymers by way of monomeric and polymeric reactive estersAngew Chem Int Ed Engl19721112110311044630476
   PubMedGoogle Scholar
• RingsdorfHMacromolecular compounds as potential protective agents against ionizing raysStrahlentherapie19671326276355584665
   PubMedGoogle Scholar
• KopecekJSoluble biomedical polymersPolimery w Medycynie19777191221593972
   PubMedGoogle Scholar
• KopecekJControlled biodegradability of polymers-a key to drug delivery systemsBiomaterials1984519256375745
   PubMed Web of Science ®Google Scholar
• DuncanRBiological effects of soluble synthetic polymers as drug carriersCrit Rev Ther Drug Carrier Syst1985142813103913527
   PubMedGoogle Scholar
• KopecekJRejmanovaPDuncanRLloydJBControlled release of drug model from N-(2-hydroxypropyl)-methacrylamide copolymersAnn N Y Acad Sci1985446931043860166
   PubMed Web of Science ®Google Scholar
• PubMed.gov [homepage on the Internet]Clinical Trails Available from http://clinicaltrials.gov/Accessed May 5, 2014
   Google Scholar
• US National Library of Medicine National Institutes of Health [homepage on the Internet] Available from http://www.ncbi.nlm.nih.gov/pubmed/Accessed September 8, 2014
   Google Scholar
• ZhuDLiuFMaLLiuDWangZNanoparticle-based systems for t1-weighted magnetic resonance imaging contrast agentsInt J Mol Sci2013145105911060723698781
   PubMedGoogle Scholar
• MandaranoGLodhiaJEuPFerrisNJDavidsonRCowellSFDevelopment and use of iron oxide nanoparticles (Part 2): the application of iron oxide contrast agents in MRIBiomed Imaging Interv J20106114
   Google Scholar
• CorotCRobertPIdeeJMPortMRecent advances in iron oxide nanocrystal technology for medical imagingAdv Drug Deliv Rev200658141471150417116343
   PubMed Web of Science ®Google Scholar
• BourrinetPBengeleHHBonnemainBPreclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agentInvest Radiol200641331332416481915
   PubMed Web of Science ®Google Scholar
• WeinsteinJSVarallyayCGDosaESuperparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a reviewJ Cereb Blood Flow Metab2010301153519756021
   PubMed Web of Science ®Google Scholar
• WangYXSuperparamagnetic iron oxide based MRI contrast agents: current status of clinical applicationQuant Imaging Med Surg201111354023256052
   PubMedGoogle Scholar
• SchroeterMFrankeCStollGHoehnMDynamic changes of magnetic resonance imaging abnormalities in relation to inflammation and glial responses after photothrombotic cerebral infarction in the rat brainActa Neuropathol200110121142211271365
   PubMedGoogle Scholar
• BullivantJPZhaoSWillenbergBJKozissnikBBatichCDDobsonJMaterials characterization of Feraheme/ferumoxytol and preliminary evaluation of its potential for magnetic fluid hyperthermiaInt J Mol Sci2013149175011751024065092
   PubMed Web of Science ®Google Scholar
• ProvenzanoRSchillerBRaoMCoyneDBrennerLPereiraBJFerumoxytol as an intravenous iron replacement therapy in hemodialysis patientsClin J Am Soc Nephrol20094238639319176796
   PubMed Web of Science ®Google Scholar
• WeisslederRElizondoGWittenbergJRabitoCABengeleHHJosephsonLUltrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imagingRadiology199017524894932326474
   PubMed Web of Science ®Google Scholar
• PaulKGFrigoTBGromanJYGromanEVSynthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharidesBioconjug Chem200415239440115025537
   PubMedGoogle Scholar
• JahnMRAndreasenHBFuttererSA comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implicationsEur J Pharm Biopharm201178348049121439379
   PubMed Web of Science ®Google Scholar
• BalakrishnanVSRaoMKauszATPhysicochemical properties of ferumoxytol, a new intravenous iron preparationEur J Clin Invest200939648949619397688
   PubMed Web of Science ®Google Scholar
• SpinowitzBSSchwenkMHJacobsPMThe safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patientsKidney Int20056841801180716164657
   PubMedGoogle Scholar
• HudginsPAAnzaiYMorrisMRLucasMAFerumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose studyAJNR Am J Neuroradiol200223464965611950660
   PubMedGoogle Scholar
• MullerKSkepperJNPosfaiMEffect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitroBiomaterials2007281629164217178155
   PubMed Web of Science ®Google Scholar
• GromanEVJosephsonLLewisJMinventorsAdvanced Magnetics, Incorporated, assignee. Magnetic resonance imaging. United States patent US4827945 A591989
   Google Scholar
• MoldayRSMoldayLLSeparation of cells labeled with immunospecific iron dextran microspheres using high gradient magnetic chromatographyFEBS Lett198417022322386373372
   PubMedGoogle Scholar
• JungCWJacobsPPhysical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsilMagn Reson Imaging19951356616748569441
   PubMed Web of Science ®Google Scholar
• JungCWSurface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsilMagn Reson Imaging19951356756918569442
   PubMed Web of Science ®Google Scholar
• JaetaoJEButlerKSAdolphiNLEnhanced leukemia cell detection using a novel magnetic needle and nanoparticlesCancer Res200969218310831619808954
   PubMedGoogle Scholar
• AdolphiNLHuberDLBryantHCCharacterization of single-core magnetite nanoparticles for magnetic imaging by SQUID relaxometryPhys Med Biol201055195985600320858918
   PubMedGoogle Scholar
• AdolphiNLHuberDLJaetaoJECharacterization of magnetite nanoparticles for SQUID-relaxometry and magnetic needle biopsyJ Magn Magn Mater20093211459146420161153
   PubMedGoogle Scholar
• BradburyMSPhillipsEMonteroPHClinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventionsIntegr Biol (Camb)201351748623138852
   PubMed Web of Science ®Google Scholar
• PetryayevaEKrullUJLocalized surface plasmon resonance: nanostructures, bioassays and biosensing – a reviewAnal Chim Acta201170682421995909
   PubMed Web of Science ®Google Scholar
• CobleyCMAuLChenJXiaYTargeting gold nanocages to cancer cells for photothermal destruction and drug deliveryExpert Opin Drug Deliv20107557758720345327
   PubMed Web of Science ®Google Scholar
• KhlebtsovNBogatyrevVDykmanLAnalytical and theranostic applications of gold nanoparticles and multifunctional nanocompositesTheranostics2013316718023471188
   PubMed Web of Science ®Google Scholar
• SikdarDRukhlenkoIDChengWPremaratneMEffect of number density on optimal design of gold nanoshells for plasmonic photothermal therapyBiomed Opt Express201341153123304644
   PubMedGoogle Scholar
• KharlamovANPlasmonic photothermal therapy for atheroregression below Glagov thresholdFuture Cardiol20139340542523668744
   PubMedGoogle Scholar
• KharlamovANTyurninaAEVeselovaVSNovoselovaOSFilatovaASPlasmonics for treatment of atherosclerosis: Results of NANOM-FIM trialJ Nanomed Nanotechnol20134160
   Google Scholar
• KharlamovANGabinskyJLPlasmonic photothermic and stem cell therapy of atherosclerotic plaque as a novel nanotool for angioplasty and artery remodelingRejuvenation Res20121522223022533437
   PubMedGoogle Scholar
• StoeberWFinkABohnEControlled growth of monodisperse silica spheres in the micron size rangeJ Colloid Interface Sci1968266269
   Google Scholar
• LeeKYLeeYWKwonKHeoJKimJHanSWOne-step fabrication of gold nanoparticles-silica composites with enhanced catalytic activityChem Phys Lett20084537781
   Google Scholar
• BaoCCondeJPoloEA promising road with challenges: where are gold nanoparticles in translational research?Nanomedicine (London)201491523532370
   PubMed Web of Science ®Google Scholar
• CondeJDiasJTMorosMBaptistaPVde la FuenteJMRevisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicineFront Chem20142127
   Web of Science ®Google Scholar
• MarillJAnesaryNMZhangPHafnium oxide nanoparticles: toward an in vitro predictive biological effect?Radiat Oncol2014915024981953
   PubMed Web of Science ®Google Scholar
• PottierABorghiELevyLNew use of metals as nanosized radioenhancersAnticancer Res20143444345324403500
   PubMed Web of Science ®Google Scholar
• LevyLPottierARouetAMarillJDevauxCGermainMinventorsNanobiotix, assigneeInorganic nanoparticles of high density to destroy cells in vivo. United States patent US8845507B2642009
   Google Scholar
• MaggiorellaLBarouchGDevauxCNanoscale radiotherapy with hafnium oxide nanoparticlesFuture Oncol2012891167118123030491
   PubMed Web of Science ®Google Scholar